← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Aurora Cannabis Inc. (ACB) 10-Year Financial Performance & Capital Metrics

ACB • • Industrial / General
HealthcareSpecialty & Generic PharmaCannabis & Hemp ProductsMedical Cannabis Producers
AboutAurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.Show more
  • Revenue $343M +27.0%
  • EBITDA $27M +305.5%
  • Net Income $2M +102.3%
  • EPS (Diluted) 0.03 +102.2%
  • Gross Margin 54.65% +12.4%
  • EBITDA Margin 8.01% +261.8%
  • Operating Margin 1.44% +108.4%
  • Net Margin 0.46% +101.8%
  • ROE 0.26% +102.1%
  • ROIC 0.65% +109.4%
  • Debt/Equity 0.17 -1.3%
  • Interest Coverage 0.59 +117.9%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 8/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y5.02%
3Y15.75%
TTM25.05%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM194.01%

EPS CAGR

10Y-
5Y-
3Y-
TTM33.35%

ROCE

10Y Avg-14.93%
5Y Avg-11.21%
3Y Avg-10.42%
Latest0.68%

Peer Comparison

Medical Cannabis Producers
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
ACBAurora Cannabis Inc.239.88M4.24148.7727.01%7.68%4.54%0.17
IXHLIncannex Healthcare Limited132.26M0.38-0.28378.7%-1671.96%-466.4%0.02
TLRYTilray Brands, Inc.1.13B9.71-0.294.84%-252.55%-136.55%0.22
IMCCIM Cannabis Corp.7.08M1.35-0.3010.71%-8.96%-109.13%5.73
AKANAkanda Corp.190.81K1.31-0.33-61.27%-12.14%-8.5%0.08
INCRInterCure Ltd.52M0.95-0.67-32.82%-28.38%-17.05%0.53
FLGCFlora Growth Corp.6.84M6.54-5.03-21.78%-32.14%-24.58%1.09

Profit & Loss

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Mar 2023Mar 2024Mar 2025
Sales/Revenue+1.44M18.07M55.2M245.54M268.7M245.25M221.34M223.8M270.28M343.29M
Revenue Growth %-11.56%2.06%3.45%0.09%-0.09%-0.1%0.01%0.21%0.27%
Cost of Goods Sold+-763K2.01M11.68M103.1M288.64M266.81M200.11M209.02M138.82M155.69M
COGS % of Revenue-0.53%0.11%0.21%0.42%1.07%1.09%0.9%0.93%0.51%0.45%
Gross Profit+2.2M16.06M43.52M142.44M-19.93M-21.56M21.23M14.78M131.46M187.61M
Gross Margin %1.53%0.89%0.79%0.58%-0.07%-0.09%0.1%0.07%0.49%0.55%
Gross Profit Growth %8.22%6.29%1.71%2.27%-1.14%-0.08%1.98%-0.3%7.89%0.43%
Operating Expenses+6.79M27.25M139.29M460.72M445.85M261.26M252.67M221.98M177.91M182.66M
OpEx % of Revenue4.72%1.51%2.52%1.88%1.66%1.07%1.14%0.99%0.66%0.53%
Selling, General & Admin5.63M24.67M109.86M365.38M345.75M194.88M188.99M170.47M156.88M166.47M
SG&A % of Revenue3.92%1.37%1.99%1.49%1.29%0.79%0.85%0.76%0.58%0.48%
Research & Development565K314K1.68M14.78M26.03M11.45M10.39M5.77M3.57M3.68M
R&D % of Revenue0.39%0.02%0.03%0.06%0.1%0.05%0.05%0.03%0.01%0.01%
Other Operating Expenses593K2.27M27.75M80.56M74.07M54.94M53.29M45.73M17.46M12.52M
Operating Income+-4.59M-11.19M-95.77M-318.28M-465.78M-282.82M-231.45M-207.19M-46.45M4.95M
Operating Margin %-3.19%-0.62%-1.74%-1.3%-1.73%-1.15%-1.05%-0.93%-0.17%0.01%
Operating Income Growth %-0.05%-1.44%-7.56%-2.32%-0.46%0.39%0.18%0.1%0.78%1.11%
EBITDA+-4M-10.11M-83.51M-230.02M-351.06M-184.74M-137.79M-154.6M-13.38M27.5M
EBITDA Margin %-2.78%-0.56%-1.51%-0.94%-1.31%-0.75%-0.62%-0.69%-0.05%0.08%
EBITDA Growth %0.02%-1.53%-7.26%-1.75%-0.53%0.47%0.25%-0.12%0.91%3.05%
D&A (Non-Cash Add-back)593K1.09M12.26M88.25M114.72M98.08M93.66M52.59M33.07M22.55M
EBIT-5.25M-15.97M89.09M-291.24M-3.26B-633.36M-1.65B-187.59M-45.41M28.8M
Net Interest Income+-1.37M-5.72M-9.25M-35.73M-70.2M-60.69M-67.31M-20.46M-1.37M3.08M
Interest Income73K861K2.52M3.68M5.91M5.75M4.51M19M12.81M11.51M
Interest Expense619K1.29M11.76M39.41M76.11M66.44M71.81M39.46M14.19M8.42M
Other Income/Expense-1.28M-6.07M173.1M-12.37M-2.87B-416.98M-1.49B-576.51M-13.15M15.43M
Pretax Income+-5.87M-17.26M77.33M-330.65M-3.34B-699.8M-1.72B-783.7M-59.6M20.38M
Pretax Margin %-4.08%-0.96%1.4%-1.35%-12.43%-2.85%-7.77%-3.5%-0.22%0.06%
Income Tax+-149K-4.3M8.1M-29.91M-82.23M-6.32M-2.14M16.55M-554K4.62M
Effective Tax Rate %0.97%0.75%0.93%0.89%0.98%0.99%1%1.04%1.16%0.08%
Net Income+-5.72M-12.97M71.94M-293.51M-3.28B-693.63M-1.72B-816.63M-69.33M1.59M
Net Margin %-3.98%-0.72%1.3%-1.2%-12.22%-2.83%-7.76%-3.65%-0.26%0%
Net Income Growth %0.4%-1.27%6.55%-5.08%-10.18%0.79%-1.48%0.52%0.92%1.02%
Net Income (Continuing)-5.72M-12.97M69.23M-300.74M-3.26B-693.48M-1.72B-800.25M-59.05M15.76M
Discontinued Operations000144K-51.86M-1.61M0-23.66M-10.28M-14.17M
Minority Interest004.56M4.41M-24.36M0511K31.06M42.1M41.42M
EPS (Diluted)+-5.32-6.0018.00-36.65-333.92-40.92-79.92-8.17-1.280.03
EPS Growth %0.46%-0.13%4%-3.04%-8.11%0.88%-0.95%0.9%0.84%1.02%
EPS (Basic)-5.32-5.5818.77-36.65-333.92-40.92-79.92-8.17-1.280.03
Diluted Shares Outstanding1.07M2.33M3.93M8.01M9.68M16.91M21.49M32.27M51.26M55.75M
Basic Shares Outstanding1.07M2.16M4M8.01M9.83M16.95M21.49M32.27M51.26M54.88M
Dividend Payout Ratio----------

Balance Sheet

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Mar 2023Mar 2024Mar 2025
Total Current Assets+5.24M193.61M219.7M664.17M420.74M665.89M745.12M479.93M426.61M478.33M
Cash & Short-Term Investments169.58K174.64M149.37M315.98M169.25M425.21M439.14M300.84M140.13M138.47M
Cash Only169.58K159.8M89.19M172.73M162.18M421.46M437.81M300.84M136.09M137.92M
Short-Term Investments014.85M60.18M143.25M7.07M3.75M1.33M04.04M554K
Accounts Receivable86.17K5.63M15.1M112.33M54.11M56.48M47.05M41.34M45.41M42.47M
Days Sales Outstanding21.86113.7499.83166.9873.584.0677.5967.4361.3345.16
Inventory4.16M11.79M43.22M165.48M157.26M137.72M139.93M128.82M186.38M239.09M
Days Inventory Outstanding-1.99K2.14K1.35K585.85198.87188.4255.22224.95490.04560.54
Other Current Assets1.85M1.54M13.62M51.84M22.14M35.31M112.47M8.92M54.69M58.29M
Total Non-Current Assets+13.15M129.07M1.69B4.84B2.36B1.94B339.24M446.39M412.07M374.34M
Property, Plant & Equipment11.37M45.52M246.35M765.57M946.38M606.09M233.47M322.97M294.32M268.11M
Fixed Asset Turnover0.13x0.40x0.22x0.32x0.28x0.40x0.95x0.69x0.92x1.28x
Goodwill041.1M729.05M3.17B928.43M887.74M018.71M43.18M43.87M
Intangible Assets282K31.09M256.23M688.37M412.27M367.45M70.7M61.4M40.85M45.16M
Long-Term Investments1.78M11.07M334.44M118.84M18.11M289K1.21M13.74M00
Other Non-Current Assets-282K292K124.94M-23.87M-91.5M77.27M33.87M14.06M18.37M12.98M
Total Assets+18.4M322.68M1.91B5.5B2.78B2.6B1.08B926.32M838.67M852.67M
Asset Turnover0.08x0.06x0.03x0.04x0.10x0.09x0.20x0.24x0.32x0.40x
Asset Growth %0.36%16.54%4.92%1.88%-0.49%-0.06%-0.58%-0.15%-0.09%0.02%
Total Current Liabilities+8M23.46M75.17M436.37M272.81M116.38M130.86M242.31M124.62M110.86M
Accounts Payable1.69M8.75M47.46M38.67M95.57M13.28M13.86M21.94M20.32M27.62M
Days Payables Outstanding-806.921.59K1.48K136.91120.8618.1625.2838.3253.4464.75
Short-Term Debt6.05M69K2.45M249.67M152.62M34.75M26.85M147.56M52.36M21.51M
Deferred Revenue (Current)27.63K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities233.44K13.22M22.99M146.55M-74.48M12.95M23.96M49.13M5.61M1.69M
Current Ratio0.66x8.25x2.92x1.52x1.54x5.72x5.69x1.98x3.42x4.31x
Quick Ratio0.14x7.75x2.35x1.14x0.97x4.54x4.62x1.45x1.93x2.16x
Cash Conversion Cycle-1.16K665.14-32.74615.92151.51254.3307.53254.07497.92540.95
Total Non-Current Liabilities+4.44M80.28M272.42M676.42M384.44M450.66M291.14M166.88M112.18M133.21M
Long-Term Debt4.44M63.82M200.76M395.16M378.63M293.18M199.65M36.16M4.9M40.19M
Capital Lease Obligations0000065.43M36.84M042.68M37.49M
Deferred Tax Liabilities05.94M69.41M91.89M3.95M02.86M16.75M16.19M1.9M
Other Non-Current Liabilities00011.98M37K92.04M51.8M70.17M48.42M53.63M
Total Liabilities12.43M103.75M347.58M1.11B657.25M567.03M422M409.19M236.8M244.07M
Total Debt+10.49M63.89M203.21M644.83M531.25M399.55M269.49M227.52M104.79M104.58M
Net Debt10.32M-95.91M114.02M472.1M369.07M-21.91M-168.32M-73.32M-31.3M-33.34M
Debt / Equity1.76x0.29x0.13x0.15x0.25x0.20x0.41x0.44x0.17x0.17x
Debt / EBITDA---------3.80x
Net Debt / EBITDA----------1.21x
Interest Coverage-7.42x-8.66x-8.14x-8.08x-6.12x-4.26x-3.22x-5.25x-3.27x0.59x
Total Equity+5.96M218.93M1.56B4.39B2.13B2.04B662.35M517.14M601.87M608.59M
Equity Growth %0.56%35.72%6.14%1.81%-0.52%-0.04%-0.67%-0.22%0.16%0.01%
Book Value per Share5.5594.15397.97547.91219.78120.4930.8216.0211.7410.92
Total Shareholders' Equity5.96M218.93M1.56B4.39B2.15B2.04B661.84M486.08M559.77M567.17M
Common Stock17.15M221.45M1.47B4.67B5.79B6.42B6.75B6.84B6.97B6.99B
Retained Earnings-16.92M-28.43M87.75M-283.64M-3.59B-4.32B-6.04B-6.3B-6.37B-6.37B
Treasury Stock0000000000
Accumulated OCI5.73M25.91M4.39M-3.84M-41.8M-65.51M-54.51M-58.33M-43.71M-56.24M
Minority Interest004.56M4.41M-24.36M0511K31.06M42.1M41.42M

Cash Flow

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Mar 2023Mar 2024Mar 2025
Cash from Operations+-6.77M-13.38M-81.67M-192.25M-342.14M-210.58M-110.27M-115.82M-68.51M16M
Operating CF Margin %-4.71%-0.74%-1.48%-0.78%-1.27%-0.86%-0.5%-0.52%-0.25%0.05%
Operating CF Growth %-1.04%-0.98%-5.1%-1.35%-0.78%0.38%0.48%-0.05%0.41%1.23%
Net Income-5.72M-12.97M69.23M-300.74M-3.26B-693.48M-1.72B-265.33M-59.05M15.76M
Depreciation & Amortization593K1.09M12.26M88.25M114.72M98.08M93.66M43.57M33.07M22.55M
Stock-Based Compensation913K7.58M37.45M107.04M59.18M20.24M13.76M16.89M12.72M11.52M
Deferred Taxes-70K-4.28M6.44M-23.91M-77.14M-6.44M-2.19M-18.4M-1.67M-3.19M
Other Non-Cash Items-2.2M-2.35M-181.65M-25.61M2.81B370.63M1.45B190.11M-37.96M-40.85M
Working Capital Changes-286K-2.46M-25.39M-37.28M7.59M397K52.65M-25.12M-15.63M10.21M
Change in Receivables542K-1.62M-12.36M-68.52M55.16M7.37M18.34M5.53M-4.33M5.24M
Change in Inventory-1.13M-1.68M-8.99M-50.42M-26.32M8.45M21.07M49.03M3.62M-15.05M
Change in Payables922K2.61M3.1M100.57M-22.55M-28.29M6.76M-8.06M-15.7M14.91M
Cash from Investing+-1.89M-49.34M-536.85M-312.3M-245.43M-26.91M-36.17M-27.29M-5.49M-14.33M
Capital Expenditures-1.89M-25.72M-136.94M-414.19M-348.81M-53.08M-32.21M-12.13M-16.96M-18.86M
CapEx % of Revenue1.31%1.42%2.48%1.69%1.3%0.22%0.15%0.05%0.06%0.05%
Acquisitions----------
Investments----------
Other Investing0-6.75M-895K-8.85M-13.34M14.78M19.46M16K12.02M-956K
Cash from Financing+8.6M221.99M535.15M597.55M582.56M521.95M147.78M-56.48M-47.92M-116K
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-315K-3.43M-25.27M-45.52M42.96M-21.15M-31.58M-95.21M-89K689K
Net Change in Cash----------
Free Cash Flow+-8.66M-39.1M-218.61M-606.43M-690.96M-263.66M-142.48M-127.95M-85.46M-2.85M
FCF Margin %-6.02%-2.16%-3.96%-2.47%-2.57%-1.08%-0.64%-0.57%-0.32%-0.01%
FCF Growth %0.22%-3.52%-4.59%-1.77%-0.14%0.62%0.46%0.1%0.33%0.97%
FCF per Share-8.05-16.81-55.66-75.69-71.41-15.59-6.63-3.96-1.67-0.05
FCF Conversion (FCF/Net Income)1.18x1.03x-1.14x0.65x0.10x0.30x0.06x0.14x0.99x10.06x
Interest Paid-471K7.07M18.05M47.9M34.16M27.73M-11.7M6.84M
Taxes Paid---------928K

Key Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)-116.86%-11.53%8.07%-9.86%-100.75%-33.31%-127.23%-138.47%-12.39%0.26%
Return on Invested Capital (ROIC)-24.44%-12.05%-7.98%-7.3%-9.5%-9.4%-13.83%-33.14%-6.87%0.65%
Gross Margin153.02%88.87%78.84%58.01%-7.42%-8.79%9.59%6.61%48.64%54.65%
Net Margin-397.71%-71.78%130.33%-119.54%-1221.68%-282.82%-776.02%-364.88%-25.65%0.46%
Debt / Equity1.76x0.29x0.13x0.15x0.25x0.20x0.41x0.44x0.17x0.17x
Interest Coverage-7.42x-8.66x-8.14x-8.08x-6.12x-4.26x-3.22x-5.25x-3.27x0.59x
FCF Conversion1.18x1.03x-1.14x0.65x0.10x0.30x0.06x0.14x0.99x10.06x
Revenue Growth-1155.52%205.51%344.84%9.44%-8.73%-9.75%1.11%20.77%27.01%

Revenue by Geography

20192020202120222025
Europe----83.35M
Europe Growth-----
Country of domicile265.84M--159.46M-
Country of domicile Growth-----
European Union11.79M21.53M29.98M61.52M-
European Union Growth-82.60%39.27%105.20%-
Other Geographical Areas3.47M2.1M4.2M359K-
Other Geographical Areas Growth--39.42%99.81%-91.45%-

Frequently Asked Questions

Valuation & Price

Aurora Cannabis Inc. (ACB) has a price-to-earnings (P/E) ratio of 148.8x. This suggests investors expect higher future growth.

Growth & Financials

Aurora Cannabis Inc. (ACB) reported $348.1M in revenue for fiscal year 2025.

Aurora Cannabis Inc. (ACB) grew revenue by 27.0% over the past year. This is strong growth.

Yes, Aurora Cannabis Inc. (ACB) is profitable, generating $26.7M in net income for fiscal year 2025 (0.5% net margin).

Dividend & Returns

Aurora Cannabis Inc. (ACB) has a return on equity (ROE) of 0.3%. This is below average, suggesting room for improvement.

Aurora Cannabis Inc. (ACB) had negative free cash flow of $1.0M in fiscal year 2025, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.